CD4 and colitis: To determine whether bortezomib treatment induced T cell apoptosis, thereby suppressing DSS-induced colitis, the percentages of Annexin-V/7-AAD+ CD4+ and CD8+ T cells in mesenteric lymph nodes were assessed 7 days after the induction of colitis.